BridgeBio Pharma, Inc. (BBIO) income statement
BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$78.01+1.21 (+1.58%)
Close on Nov 18, 2026Market cap $15.20BP/E –Yield –
BridgeBio Pharma, Inc. financial ratios
See a number that looks wrong?